Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- EAPI.PA
- Price
- 2.97
- Stock movement down
- -0.06 (-2.11%)
- Company name
- Euroapi SAS
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Markedsværdi
- 282.55M
- Ent værdi
- 906.15M
- Pris/omsætning
- 0.23
- Pris/bog
- 0.32
- Udbytte afkast
- -
- Udbyttevækst
- -
- Vekst år
- -
- FCF-udbetaling
- -
- Efterfølgende P/E
- -
- Fremtidig P/E
- -
- PEG
- -
- EPS-vekst
- -
- 1 års afkast
- 0.88%
- 3 års afkast
- -43.56%
- 5 års afkast
- -
- 10 års afkast
- -
Senest opdateret: 2025-06-22
UDBYTTE
EAPI.PA betaler ikke udbytte
VÆRDIANSÆTTELSE
Værdiansættelsesforhold
Loading...
Værdiansættelsesforhold-data
| Efterfølgende P/E | - |
| Pris til OCF | 2.14 |
| Pris til FCF | - |
| Pris til EBITDA | 1.65 |
| EV i forhold til EBITDA | 5.30 |
Værdiansættelse (salg/bogført værdi)
Loading...
Værdiansættelse (salg/bogført værdi)-data
| Pris til omsætning | 0.23 |
| Pris til egenkapital | 0.32 |
| EV i forhold til salg | 0.74 |
ØKONOMI
Pr. aktie
Loading...
Data pr. aktie
| Aktuelt antal aktier | 95.26M |
| EPS (TTM) | -4.39 |
| FCF pr. aktie (TTM) | -0.30 |
Resultatopgørelse
Loading...
Resultatopgørelse-data
| Omsætning (TTM) | 1.23B |
| Bruttofortjeneste (TTM) | 196.25M |
| Driftsindkomst (TTM) | -29.75M |
| Nettoindkomst (TTM) | -413.55M |
| EPS (TTM) | -4.39 |
| EPS (1 år frem) | -0.17 |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | 15.99% |
| Driftsmargin (TTM) | -2.42% |
| Fortjenstmargin (TTM) | -33.68% |
Balance
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
| Kontanter | 282.80M |
| Nettotilgodehavender | 215.80M |
| Omsætningsaktiver i alt | 1.16B |
| Goodwill | 4.60M |
| Immaterielle aktiver | 38.90M |
| Ejendomme, anlæg og udstyr | 2.42B |
| Sum aktiver | 1.80B |
| Kreditor | 143.60M |
| Kortfristet/nuværende langsigtet gæld | 471.60M |
| Summen af kortfristede forpligtelser | 735.90M |
| Sum gæld | 906.40M |
| Aktionærernes egenkapital | 889.50M |
| Materielle nettoaktiver | 0.00 |
Likviditet
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
| Likviditet fra driften (TTM) | 132.05M |
| Investeringsudgifter (TTM) | 160.35M |
| Fri pengestrøm (TTM) | -28.30M |
| Udbetalt udbytte (TTM) | 0.00 |
Finansiel indkomst
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
| Egenkapitalafkast | -46.49% |
| Afkast af aktiver | -23.03% |
| Afkast af investeret kapital | -30.71% |
| Kontant afkast af investeret kapital | -2.10% |
INFORMATION OM AKTIER
Aktiediagram
Loading...
Aktiekurs-data
| Åbning | 3.03 |
| Daglig høj | 3.10 |
| Daglig lav | 2.95 |
| Daglig volumen | 81K |
| Højeste gennem alle tider | 18.71 |
| 1 års analytiker estimat | 3.38 |
| Beta | 0.56 |
| EPS (TTM) | -4.39 |
| Udbytte pr. aktie | - |
| Ex-div dato | - |
| Næste dato for resultatpræsentation | 29 Jul 2025 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| EAPI.PA | S&P500 | |
| Nuværende prisfald fra top notering | -84.15% | -3.04% |
| Højeste prisfald | -87.71% | -56.47% |
| Højeste efterår dato | 9 Apr 2025 | 9 Mar 2009 |
| Gennemsnitlig fald fra toppen | -53.41% | -11.04% |
| Gennemsnitlig tid til nyt højdepunkt | 44 days | 12 days |
| Maks. tid til nyt højdepunkt | 683 days | 1805 days |
OPLYSNINGER OM VIRKSOMHEDEN
Markedsværdi
282.55M
Markedsværdi kategori
Small-cap
Beskrivelse
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. The company was incorporated in 2020 and is based in Paris, France.
Personale
3650
Hjemmeside
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
France
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
Press Release Paris – June 30, 2025 – EUROAPI today announced the signing of a share purchase agreement (SPA) for the sale of 100% of EUROAPI UK Ltd, the subsidiary operating its Haverhill manufacturi...
30. juni 2025
Press Release Paris – June 4, 2025 – EUROAPI, a European leader in the production of active pharmaceutical ingredients (API) and contract development and manufacturing organization (CDMO), is pleased ...
4. juni 2025
Press Release - Approval of all resolutions submitted by the Board of Directors, including the unconsolidated and consolidated financial statements for the year 2024 - Paris – May 21, 2025 – The Combi...
21. maj 2025
Press Release Paris – April 29, 2025 – EUROAPI’s shareholders are invited to attend the Combined General Meeting to be held on Wednesday May 21, 2025 at 10:30 a.m. (CET) at 15 bis, rue Traversière 750...
29. april 2025
Press Release Paris – April 1, 2025 – EUROAPI announces the publication of its 2024 Universal Registration Document in ESEF format, filed with the French Autorité des marchés financiers (AMF) on April...
1. april 2025
Despite a challenging year with decreased sales and EBITDA, Euroapi SA (EAPIF) shows resilience through strategic client acquisitions and sustainability commitments.
5. marts 2025
Press Release Paris, 3rd March, 2025 Full-year 2024 results1: Operational resilience and strong increase in Free Cash Flow before financing in a challenging environment Net sales down 10.0% to €911.9 ...
3. marts 2025
Press Release A tour of Vertolaye manufacturing and storage facilities highlighted EUROAPI’s long-term commitment to health sovereignty Paris and Vertolaye - January 6, 2025 – The French Minister for ...
6. januar 2025
Press Release Emmanuel Blin appointed Independent Chair of the Board of DirectorsDavid Seignolle appointed Chief Executive OfficerFull-year 2024 guidance maintained Paris – December 9, 2024 – With FOC...
9. december 2024
Press Release Paris – October 16, 2024 – Olivier Falut has been appointed EUROAPI’s Chief Financial Officer, effective October 17, 2024, and will be a member of the Executive Committee. He is taking o...
16. oktober 2024
Næste side